HemaSphere (Aug 2022)
P-089: EVALUATION OF SAFETY AND EFFICACY OF HBS-SAILIN®: A POTENT INGENIOUS ANTI-SICKLING AGENT THAT REDUCES PAIN AND IMPROVES THE QUALITY OF LIFE IN SICKLE CELL PATIENTS.
Abstract
No abstracts available.
HemaSphere (Aug 2022)